Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H8N2O3S |
Molecular Weight | 212.226 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1CN(C2=CC=CC=C2)S(=O)(=O)N1
InChI
InChIKey=LDCZCUKQWRZSDT-UHFFFAOYSA-N
InChI=1S/C8H8N2O3S/c11-8-6-10(14(12,13)9-8)7-4-2-1-3-5-7/h1-5H,6H2,(H,9,11)
Molecular Formula | C8H8N2O3S |
Molecular Weight | 212.226 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Potent and specific inhibition of human leukocyte elastase, cathepsin G and proteinase 3 by sulfone derivatives employing the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold. | 1998 Jun |
|
Utilization of the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold in the design of potent inhibitors of serine proteases: SAR studies using carboxylates. | 2000 May |
|
Structure-based design of protein tyrosine phosphatase-1B inhibitors. | 2005 May 16 |
|
A comparative QSAR on 1,2,5-thiadiazolidin-3-one 1,1-dioxide compounds as selective inhibitors of human serine proteinases. | 2011 Nov |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:32:38 GMT 2023
by
admin
on
Sat Dec 16 15:32:38 GMT 2023
|
Record UNII |
L4SBH33TJR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
L4SBH33TJR
Created by
admin on Sat Dec 16 15:32:38 GMT 2023 , Edited by admin on Sat Dec 16 15:32:38 GMT 2023
|
PRIMARY | |||
|
612530-44-6
Created by
admin on Sat Dec 16 15:32:38 GMT 2023 , Edited by admin on Sat Dec 16 15:32:38 GMT 2023
|
PRIMARY | |||
|
4369452
Created by
admin on Sat Dec 16 15:32:38 GMT 2023 , Edited by admin on Sat Dec 16 15:32:38 GMT 2023
|
PRIMARY |